Povidone iodine treatment is deleterious to human ocular surface conjunctival cells in culture.

conjunctiva ocular surface

Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
2020
Historique:
received: 19 06 2020
revised: 07 08 2020
accepted: 19 08 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

To determine the effect of povidone iodine (PI), an antiseptic commonly used prior to ocular surgery, on viability of mixed populations of conjunctival stratified squamous and goblet cells, purified conjunctival goblet cells and purified conjunctival stromal fibroblasts in primary culture. Mixed population of epithelial cells (stratified squamous and goblet cells), goblet cells and fibroblasts were grown in culture from pieces of human conjunctiva using either supplemented DMEM/F12 or RPMI. Cell type was evaluated by immunofluorescence microscopy. Cells were treated for 5 min with phosphate-buffered saline (PBS); 0.25%, 2.5%, 5% or 10% PI in PBS; or a positive control of 30% H Mixed populations of epithelial cells, goblet cells and fibroblasts were characterised by immunofluorescence microscopy. As determined with Alamar Blue fluorescence, all concentrations of PI significantly decreased the number of cells from all three preparation types compared with PBS. As determined by calcein/EH-1 viability test, mixed populations of cells and fibroblasts were less sensitive to PI treatment than goblet cells. All concentrations of PI, except for 0.25% used with goblet cells, substantially increased the number of dead cells for all cell populations. The H We conclude that PI, which is commonly used prior to ocular surgeries, is detrimental to human conjunctival stratified squamous cells, goblet cells and fibroblasts in culture.

Identifiants

pubmed: 32995498
doi: 10.1136/bmjophth-2020-000545
pii: bmjophth-2020-000545
pmc: PMC7497553
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e000545

Subventions

Organisme : NEI NIH HHS
ID : R01 EY019470
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Antimicrob Agents Chemother. 1984 Dec;26(6):793-6
pubmed: 6524896
Mucosal Immunol. 2013 Nov;6(6):1119-30
pubmed: 23462912
Acta Ophthalmol. 2017 Aug;95(5):e373-e378
pubmed: 28271619
PLoS One. 2017 Mar 1;12(3):e0171099
pubmed: 28248962
J Immunol. 2011 Apr 1;186(7):4455-66
pubmed: 21357260
Jpn J Ophthalmol. 2014 Nov;58(6):522-7
pubmed: 25230910
Ophthalmic Res. 2019;62(3):166-172
pubmed: 31352456
Cutan Ocul Toxicol. 2017 Dec;36(4):343-346
pubmed: 28166657
Exp Eye Res. 2012 Oct;103:99-113
pubmed: 22975404
Br J Ophthalmol. 2003 Feb;87(2):163-7
pubmed: 12543744
PLoS One. 2013 Sep 10;8(9):e74010
pubmed: 24040145
Ophthalmology. 2016 Dec;123(12):2588-2594
pubmed: 27720552
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):797-802
pubmed: 15728533
Mucosal Immunol. 2016 Jan;9(1):206-17
pubmed: 26129651
J Coll Physicians Surg Pak. 2016 Feb;26(2):121-4
pubmed: 26876399
J Cataract Refract Surg. 2013 Jul;39(7):994-1001
pubmed: 23680628
Sci Rep. 2016 Nov 08;6:36124
pubmed: 27824117
PLoS One. 2017 Dec 19;12(12):e0189206
pubmed: 29261737
BMJ Open Ophthalmol. 2017 Nov 16;2(1):e000101
pubmed: 29354725
Exp Eye Res. 2016 Dec;153:1-7
pubmed: 27725198
Mucosal Immunol. 2017 Jan;10(1):46-57
pubmed: 27072607
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1455-64
pubmed: 11381047
BMC Ophthalmol. 2018 Jul 11;18(1):167
pubmed: 29996791
Cutan Ocul Toxicol. 2015 Mar;34(1):12-5
pubmed: 24678746
Arch Ophthalmol. 1997 Mar;115(3):357-61
pubmed: 9076208
Prog Retin Eye Res. 2002 Nov;21(6):555-76
pubmed: 12433377
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2477-86
pubmed: 12766046
Proteomes. 2015 Dec 14;3(4):496-511
pubmed: 28248282
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415888
Am J Ophthalmol. 2011 Jan;151(1):11-17.e1
pubmed: 20970112
Arch Ophthalmol. 1990 Jun;108(6):861-4
pubmed: 2112378
Invest Ophthalmol Vis Sci. 2012 May 17;53(6):2993-3003
pubmed: 22467574
Retina. 2019 Nov;39(11):2219-2224
pubmed: 30142109
Eur J Ophthalmol. 2009 Jul-Aug;19(4):560-4
pubmed: 19551669
Surv Ophthalmol. 2018 Nov - Dec;63(6):862-868
pubmed: 29778494
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2270-82
pubmed: 11527940
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):142-52
pubmed: 9008639
Ophthalmology. 1991 May;98(5):639-49; discussion 650
pubmed: 2062496
Jundishapur J Microbiol. 2014 Sep;7(9):e13108
pubmed: 25485065
Cutan Ocul Toxicol. 2009;28(3):119-24
pubmed: 19694608
Retina. 2013 May;33(5):975-81
pubmed: 23416514
Optom Vis Sci. 2017 Jul;94(7):732-741
pubmed: 28609415
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5616-23
pubmed: 18055811
J AAPOS. 2014 Aug;18(4):347-50
pubmed: 25173897
Br J Ophthalmol. 1986 Feb;70(2):122-5
pubmed: 3947607
Prog Retin Eye Res. 2016 Sep;54:49-63
pubmed: 27091323
Eur J Ophthalmol. 2012 Jul-Aug;22(4):541-6
pubmed: 22180155
Sci Rep. 2019 Oct 29;9(1):15457
pubmed: 31664078

Auteurs

William Swift (W)

Schepens Eye Research Institute, Boston, Massachusetts, USA.

Jeffrey A Bair (JA)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Ophthalmology, Harvard Medical School, Boston, MA, United States.

Wanxue Chen (W)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Michael Li (M)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Sole Lie (S)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Dayu Li (D)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Menglu Yang (M)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Marie A Shatos (MA)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Robin R Hodges (RR)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Ophthalmology, Harvard Medical School, Boston, MA, United States.

Miriam Kolko (M)

University of Copenhagen, Kobenhavn, Denmark.

Tor P Utheim (TP)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Oslo University Hospital, Oslo, Norway.

Wendell Scott (W)

Mercy Eye Clinic, Springfield, Missouri, USA.

Darlene A Dartt (DA)

Schepens Eye Research Institute, Boston, Massachusetts, USA.
Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Ophthalmology, Harvard Medical School, Boston, MA, United States.

Classifications MeSH